The bespoke conundrum

p53-neilson-jpg

The drive by regulators to ensure as much of the over-the-counter derivatives market as possible is cleared through central counterparties is progressing at full throttle. On June 17, the US government laid out its plan to overhaul the financial system. In it, the US Treasury repeated its intention, already disclosed by Treasury secretary Timothy Geithner in earlier testimony to the US Congress, to amend the Commodities Exchange Act to require all standardised OTC derivatives contracts to be

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: